non-coding sequences

NEW YORK (GenomeWeb News) – By considering sequence data for individuals assessed through the 1000 Genomes Project, a team led by researchers from Yale University and Wellcome Trust Sanger Institute came up with a computational method for prioritizing potential disease culprits — including those

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has licensed technology to Hologic after the firms settled over a patent dispute.

Genetic Technologies said it has secured A$14.5 million ($15.2 million) in licensing revenues since it filed its lawsuit in February 2010.

Genetic Technologies granted a non-exclusive license to Orchid Cellmark for a number of patents covering non-coding analysis, gene mapping, and internal standards.

The amendment extends the terms of the Quest's original non-coding license to regularize Quest's historical worldwide activities related to its genetic diagnostic and analysis products.

The patent is at the center of a lawsuit filed by Genetic Technologies against several defendants earlier this year.

The EraGen license comes a couple of days after Gen-Probe took a license to the same non-coding patents.

Gen-Probe is one of several firms that were sued by Genetic Technologies in February for alleged infringement of a patent covering methods of analyzing non-coding DNA sequences.